The Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial virus (RSV) vaccine for use ...
The European Medicines Agency has recommended the use of Pfizer's gene therapy for a rare bleeding disorder called hemophilia ...
Moderna’s mResvia is now the third FDA-approved RSV vaccine and the first one based on mRNA technology. It will compete for market share against RSV shots from GSK and Pfizer that won their FDA nods ...
Pfizer (PFE) stock gains as lung cancer therapy, Lorbrena, shows promising results in reducing disease progression or death ...
Five children who were born completely deaf have had some reversal of hearing loss after receiving a "groundbreaking" gene therapy. The clinical trial, which was co-led by Mass Eye and Ear in ...
Gene therapy is a new medical breakthrough which has, in reality, been several decades in the making. The concept was first suggested 50 years ago as a possibility for targeted treatments, but it ...
Welcome to 2024's regulatory tracker for Fierce Pharma. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications.
NEW YORK, May 31 (UPI) --Researchers are engineering ways to alter genes or swap flawed ones with healthy replacements, hoping to cure diseases or enable the body to better combat them. These ...
Stimulants are typically the go-to option for doctors prescribing treatments for attention-deficit hyperactivity disorder (ADHD). But some ADHD patients do not respond adequately to stimulants or ...
The global cell and gene therapy market is experiencing significant growth, driven by technological advancements, increasing ...
Five children who were born completely deaf have had some reversal of hearing loss after receiving a "groundbreaking" gene therapy. The clinical trial, which was co-led by Mass Eye and Ear in ...